Tuesday, May 8, 2018

Adderall maker Shire agrees £46bn takeover by Takeda

Japan’s biggest drugmaker increases offer to secure deal as Virgin Money also faces takeover

Shire, the London-listed maker of treatments for ADHD and rare diseases, has agreed a £46bn bid from Japan’s Takeda, in the biggest deal in the pharmaceutical sector since 2000.

It is the latest in a series of takeovers involving British companies. It came as Virgin Money, backed by Sir Richard Branson, said it was reviewing an all-share takeover approach worth £1.6bn from CYBG, the owner of Clydesdale and Yorkshire Bank. A deal would bring together two of Britain’s biggest challenger banks.

Related: Takeover fever: Shire agrees £46bn bid, as Virgin Money gets £1.6bn offer - business live

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2wowM7z

No comments:

Post a Comment